CHD4 deficiency was shown to reduce the recruitment of homologous recombination repair factor BRCA1, and it impaired the efficiency of homologous recombination repair, which could affect the treatment of breast cancer characterized by BRCA1/BRCA2 mutations (Abdelmohsen et al., 2012). This evidence concerns the gene BRCA1 and breast cancer.